跳至主要内容
临床试验/NL-OMON51879
NL-OMON51879尚未招募不适用

Detection of sepsis at the intensive care unit with non-invasive transcutaneous blood gas monitoring. - COSMOS

Erasmus MC, Universitair Medisch Centrum Rotterdam0 个研究点目标入组 50 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • Sepsis group:
  • Sepsis classified as 2 SIRS criteria and suspected infection
  • Signs of hypoperfusion, requiring noradrenaline administration of at least
  • 0.5 µg/min/kg
  • Written informed consent.
  • Control group:
  • No fulfillment of 2 SIRS criteria, nor suspected infection
  • No signs of hypoperfusion, noradrenaline administration of less than or equal
  • to 0.5 µg/min/kg
  • Written informed consent.

排除标准

  • Sepsis group:
  • No sepsis
  • Skin condition contraindicating transcutaneous blood gas measurements.
  • Absence of written informed consent.
  • Control group:
  • Sepsis classified as 2 SIRS criteria and suspected infection
  • Skin condition contraindicating transcutaneous blood gas measurements.
  • Absence of written informed consent.

研究者

相似试验

Detection of sepsis at the intensive care unit with... | 临床试验